Skip to main content
SpringerLink
Log in

Endovascular Femoropopliteal Interventions: Evolving Devices

  • Chapter
  • First Online:
Inflammatory Response in Cardiovascular Surgery

  • 1303 Accesses

Abstract

Peripheral arterial disease (PAD) is caused by systemic atherosclerosis and is strongly associated with cardiovascular and cerebrovascular disease. Important risk factors for PAD include age > 70, history of smoking, diabetes, hypertension, and hyperlipidemia, all known markers for cardiovascular disease [1]. While medical management in conjunction with an exercise regimen is the recommended initial approach, according to the American Heart Association/American College of Cardiology guidelines for the management of PAD, patients with lifestyle-compromising pain, nonhealing ulcers, or critical limb ischemia require invasive endovascular or surgical intervention [2]. There is some disagreement about the appropriate management of femoral-popliteal lesions among various groups of interventionalists, but the Inter-Society Consensus for the Management of PAD provides a general approach. Because of the rapidly changing technology, for many interventionalists the endovascular option is the first line of therapy, despite very poor evidence for many of the products currently on the market.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–24.

    Article  PubMed  CAS  Google Scholar 

  2. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463–654.

    Article  PubMed  Google Scholar 

  3. Lyden SP, Smouse HB. TASC II and the endovascular management of infrainguinal disease. J Endovasc Ther. 2009;16(2 Suppl 2):II5–18.

    Article  PubMed  Google Scholar 

  4. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–34.

    Article  PubMed  CAS  Google Scholar 

  5. Owens C. Chapter 4: Atherosclerosis. In: Rutherford’s vascular surgery. 7th ed. Philadelphia: Elsevier; 2010.

    Google Scholar 

  6. Bianda N, Di Valentino M, Périat D, et al. Progression of human carotid and femoral atherosclerosis: a prospective follow-up study by magnetic resonance vessel wall imaging. Eur Heart J. 2011. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21920966. Accessed 18 Dec 2011.

  7. Herisson F, Heymann M-F, Chétiveaux M, et al. Carotid and femoral atherosclerotic plaques show different morphology. Atherosclerosis. 2011;216(2):348–54.

    Article  PubMed  CAS  Google Scholar 

  8. Derksen WJM, de Vries J-PPM, Vink A, et al. Histologic atherosclerotic plaque characteristics are associated with restenosis rates after endarterectomy of the common and superficial femoral arteries. J Vasc Surg. 2010;52(3):592–9.

    Article  PubMed  Google Scholar 

  9. Hellings WE, Moll FL, De Vries J-PPM, et al. Atherosclerotic plaque composition and occurrence of restenosis after carotid endarterectomy. JAMA. 2008;299(5):547–54.

    Article  PubMed  CAS  Google Scholar 

  10. Pasterkamp G, Wensing PJ, Post MJ, et al. Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. Circulation. 1995;91(5):1444–9.

    Article  PubMed  CAS  Google Scholar 

  11. Vink A, Schoneveld AH, Borst C, Pasterkamp G. The contribution of plaque and arterial remodeling to de novo atherosclerotic luminal narrowing in the femoral artery. J Vasc Surg. 2002;36(6):1194–8.

    Article  PubMed  Google Scholar 

  12. Fowkes F, Leng GC. Bypass surgery for chronic lower limb ischaemia. Cochrane Database Syst Rev. 2008;(2):CD002000.

    Google Scholar 

  13. Romiti M, Albers M, Brochado-Neto FC, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47(5):975–81.

    Article  PubMed  Google Scholar 

  14. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996;312(7038):1061–5.

    Article  PubMed  CAS  Google Scholar 

  15. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol. 1991;17(3):758–69.

    Article  PubMed  CAS  Google Scholar 

  16. Serrano Jr CV, Ramires JA, Venturinelli M, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol. 1997;29(6):1276–83.

    Article  PubMed  CAS  Google Scholar 

  17. Schillinger M, Exner M, Mlekusch W, et al. Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J Endovasc Ther. 2002;9(1):59–66.

    Article  PubMed  Google Scholar 

  18. Joviliano EE, Piccinato CE, Dellalibera-Joviliano R, Moriya T, Évora PRB. Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts. Ann Vasc Surg. 2011;25(6):846–55.

    Article  PubMed  Google Scholar 

  19. Samson RH, Showalter DP, Lepore Jr M, Nair DG, Merigliano K. CryoPlasty therapy of the superficial femoral and popliteal arteries: a reappraisal after 44 months’ experience. J Vasc Surg. 2008;48(3):634–7.

    Article  PubMed  Google Scholar 

  20. Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011;58(11):1105–9.

    Article  PubMed  CAS  Google Scholar 

  21. Jahnke T, Mueller-Huelsbeck S, Charalambous N, et al. Prospective, randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: midterm results of the COLD study. J Vasc Interv Radiol. 2010;21(2):186–94.

    Article  PubMed  Google Scholar 

  22. Barath P, Fishbein MC, Vari S, Forrester JS. Cutting balloon: a novel approach to percutaneous angioplasty. Am J Cardiol. 1991;68(11):1249–52.

    Article  PubMed  CAS  Google Scholar 

  23. Vorwerk D, Adam G, Müller-Leisse C, Guenther RW. Hemodialysis fistulas and grafts: use of cutting balloons to dilate venous stenoses. Radiology. 1996;201(3):864–7.

    PubMed  CAS  Google Scholar 

  24. Ito S, Suzuki T, Suzuki T. Adjunctive use of cutting balloon after rotational atherectomy in a young adult with probable Kawasaki disease. J Invasive Cardiol. 2003;15(5):297–300.

    PubMed  Google Scholar 

  25. Bergersen LJ, Perry SB, Lock JE. Effect of cutting balloon angioplasty on resistant pulmonary artery stenosis. Am J Cardiol. 2003;91(2):185–9.

    Article  PubMed  Google Scholar 

  26. De Giovanni JV. Balloon angioplasty for branch pulmonary artery stenosis – cutting balloons. Catheter Cardiovasc Interv. 2007;69(3):459–67.

    Article  PubMed  Google Scholar 

  27. Nakamura M, Yock PG, Kataoka T, et al. Impact of deep vessel wall injury on acute response and remodeling of coronary artery segments after cutting balloon angioplasty. Am J Cardiol. 2003;91(1):6–11.

    Article  PubMed  Google Scholar 

  28. Kawaguchi K, Kondo T, Shumiya T, et al. Reduction of early elastic recoil by cutting balloon angioplasty as compared to conventional balloon angioplasty. J Invasive Cardiol. 2002;14(9):515–9.

    PubMed  Google Scholar 

  29. Rabbi JF, Kiran RP, Gersten G, Dudrick SJ, Dardik A. Early results with infrainguinal cutting balloon angioplasty limits distal dissection. Ann Vasc Surg. 2004;18(6):640–3.

    Article  PubMed  Google Scholar 

  30. Amighi J, Schillinger M, Dick P, et al. De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates – randomized controlled trial. Radiology. 2008;247(1):267–72.

    Article  PubMed  Google Scholar 

  31. Aslam MS, Allaqaband S, Haddadian B, et al. Subintimal angioplasty with a true reentry device for treatment of chronic total occlusion of the arteries of the lower extremity. Catheter Cardiovasc Interv. 2010. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20824749. Accessed 4 Dec 2011.

  32. Markose G, Miller FNAC, Bolia A. Subintimal angioplasty for femoro-popliteal occlusive disease. J Vasc Surg. 2010;52(5):1410–6.

    Article  PubMed  Google Scholar 

  33. Scott EC, Biuckians A, Light RE, et al. Subintimal angioplasty: our experience in the treatment of 506 infrainguinal arterial occlusions. J Vasc Surg. 2008;48(4):878–84.

    Article  PubMed  Google Scholar 

  34. Virmani R, Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol. 1999;10(6):499–506.

    Article  PubMed  CAS  Google Scholar 

  35. Moreno PR, Palacios IF, Leon MN, et al. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol. 1999;84(4):462–6, A9.

    Article  PubMed  CAS  Google Scholar 

  36. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12(1):23–31.

    Article  PubMed  CAS  Google Scholar 

  37. Minar E, Schillinger M. New stents for SFA. J Cardiovasc Surg (Torino). 2009;50(5):635–45.

    CAS  Google Scholar 

  38. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3(3):267–76.

    Article  PubMed  Google Scholar 

  39. Dick P, Wallner H, Sabeti S, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv. 2009;74(7):1090–5.

    Article  PubMed  Google Scholar 

  40. Mewissen MW. Primary nitinol stenting for femoropopliteal disease. J Endovasc Ther. 2009;16(2 Suppl 2):II63–81.

    Article  PubMed  Google Scholar 

  41. Lammer J, Dake MD, Bleyn J, et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology. 2000;217(1):95–104.

    PubMed  CAS  Google Scholar 

  42. Kedora J, Hohmann S, Garrett W, et al. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg. 2007;45(1):10–6; discussion 16.

    Article  PubMed  Google Scholar 

  43. McQuade K, Gable D, Pearl G, Theune B, Black S. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2010;52(3):584–90. discussion 590–591, 591.e1-591.e7.

    Article  PubMed  Google Scholar 

  44. Zeller T, Macharzina R, Tepe G. The potential role of DES in peripheral in-stent restenosis. J Cardiovasc Surg (Torino). 2010;51(4):561–5.

    CAS  Google Scholar 

  45. Lammer J, Bosiers M, Zeller T, et al. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg. 2011;54(2):394–401.

    Article  PubMed  Google Scholar 

  46. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16(3):331–8.

    Article  PubMed  Google Scholar 

  47. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358(7):689–99.

    Article  PubMed  CAS  Google Scholar 

  48. Zeller T, Rastan A, Schwarzwälder U, et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-­generation device: six-month results from a single-center experience. J Endovasc Ther. 2004;11(6):676–85.

    Article  PubMed  Google Scholar 

  49. McKinsey JF, Goldstein L, Khan HU, et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions. Ann Surg. 2008;248(4):519–28.

    PubMed  Google Scholar 

  50. Davies MG, Bismuth J, Saad WE, et al. Implications of in situ thrombosis and distal embolization during superficial femoral artery endoluminal intervention. Ann Vasc Surg. 2010;24(1):14–22.

    Article  PubMed  Google Scholar 

  51. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94(11):3026–49.

    Article  PubMed  CAS  Google Scholar 

  52. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47(6):1239–312.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, 6550 Fannin St. Smith Tower 1400, Houston, 77030, TX, USA

    Cassidy Duran MD & Jean Bismuth MD

Authors
  1. Cassidy Duran MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean Bismuth MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean Bismuth MD .

Editor information

Editors and Affiliations

  1. University Nove de Julho, Melo Alves 685, São Paulo, 01417-010, São Paulo, Brazil

    Edmo Atique Gabriel

  2. Pontifícia Universidade Católica de Camp, Rodovia D. Pedro I, km 136, São Paulo, 13086-900, São Paulo, Brazil

    Sthefano Atique Gabriel

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Duran, C., Bismuth, J. (2013). Endovascular Femoropopliteal Interventions: Evolving Devices. In: Gabriel, E., Gabriel, S. (eds) Inflammatory Response in Cardiovascular Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-4429-8_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4429-8_26

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4428-1

  • Online ISBN: 978-1-4471-4429-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation